Detalhe da pesquisa
1.
Response to Capmatinib in a MET Fusion-positive Cholangiocarcinoma.
Oncologist
; 28(1): 80-83, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36434677
2.
Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas.
Histopathology
; 70(7): 1089-1097, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28106924
3.
French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas.
Eur Respir J
; 46(1): 207-18, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25929957
4.
MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)-dependent oncogenic driver in vitro and in humanised HGF knock-in mice.
Mol Oncol
; 17(11): 2257-2274, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36799689
5.
Reply to 'Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas'.
Histopathology
; 71(5): 836-837, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28640961
6.
Alterations in the PI3K Pathway Drive Resistance to MET Inhibitors in NSCLC Harboring MET Exon 14 Skipping Mutations.
J Thorac Oncol
; 15(5): 741-751, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32169477
7.
Complete and prolonged response to anti-PD1 therapy in an ALK rearranged lung adenocarcinoma.
Lung Cancer
; 146: 366-369, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32553554
8.
Relevance of Detection of Mechanisms of Resistance to ALK Inhibitors in ALK-Rearranged NSCLC in Routine Practice.
Clin Lung Cancer
; 20(4): 297-304.e1, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31147208
9.
Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients.
J Thorac Oncol
; 13(12): 1873-1883, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30195702
10.
Preferential Localization of MET Expression at the Invasion Front and in Spreading Cells Through Air Spaces in Non-Small Cell Lung Carcinomas.
Am J Surg Pathol
; 41(3): 414-422, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28098570
11.
ALK rearrangements-associated renal cell carcinoma (RCC) with unique pathological features in an adult.
Pathol Res Pract
; 212(11): 1064-1066, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27554841
12.
Patterns of response to crizotinib in recurrent glioblastoma according to ALK and MET molecular profile in two patients.
CNS Oncol
; 4(6): 381-6, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26498130